Format

Send to

Choose Destination
Biotechnol Lett. 2007 Jul;29(7):995-1003. Epub 2007 Mar 16.

Biotechnological challenges of phage therapy.

Author information

1
Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland. mikael.skurnik@helsinki.fi

Abstract

The challenges for successful launching of a profitable phage therapeutic product include intellectual property rights, safety issues, reproducibility, stability and robustness of the product. A successful and marketable product would be a highly purified bacteriophage preparation containing one or several fully characterized phages, accompanied by optimized methods of administration and backed up by properly controlled efficacy and safety studies.

PMID:
17364214
DOI:
10.1007/s10529-007-9346-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center